Cargando…
The emergence of COVID-19 as a global pandemic: Understanding the epidemiology, immune response and potential therapeutic targets of SARS-CoV-2
An acute respiratory disease caused by a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that surfaced in China in late 2019, continues to spread rapidly across the globe causing serious concerns. The coronavirus disease 2019 (COVID-19) is declared as a public health emergency worldwide...
Autores principales: | Muralidar, Shibi, Ambi, Senthil Visaga, Sekaran, Saravanan, Krishnan, Uma Maheswari |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V. and Société Française de Biochimie et Biologie Moléculaire (SFBBM).
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505773/ https://www.ncbi.nlm.nih.gov/pubmed/32971147 http://dx.doi.org/10.1016/j.biochi.2020.09.018 |
Ejemplares similares
-
Pharmacology, Toxicology, and Therapeutics of Minerals in Traditional Medicine 2021
por: Liu, Jie, et al.
Publicado: (2023) -
Emerging Trends in Nano-Driven Immunotherapy for Treatment of Cancer
por: Kandasamy, Gayathri, et al.
Publicado: (2023) -
Emerging antibody-based therapeutics against SARS-CoV-2 during the global pandemic
por: Sun, Yaping, et al.
Publicado: (2020) -
Poly(1-vinylimidazole) polyplexes as novel therapeutic gene carriers for lung cancer therapy
por: Kandasamy, Gayathri, et al.
Publicado: (2020) -
RUNX Family as a Promising Biomarker and a Therapeutic Target in Bone Cancers: A Review on Its Molecular Mechanism(s) behind Tumorigenesis
por: Vimalraj, Selvaraj, et al.
Publicado: (2023)